Designs for Group Sequential Phase II Clinical Trials (Q3201547): Difference between revisions
From MaRDI portal
Removed claim: author (P16): Item:Q1235469 |
Set OpenAlex properties. |
||
| (2 intermediate revisions by 2 users not shown) | |||
| Property / author | |||
| Property / author: Harry S. Wieand / rank | |||
Normal rank | |||
| Property / MaRDI profile type | |||
| Property / MaRDI profile type: MaRDI publication profile / rank | |||
Normal rank | |||
| Property / full work available at URL | |||
| Property / full work available at URL: https://doi.org/10.2307/2531540 / rank | |||
Normal rank | |||
| Property / OpenAlex ID | |||
| Property / OpenAlex ID: W2316588149 / rank | |||
Normal rank | |||
Latest revision as of 15:28, 19 March 2024
scientific article
| Language | Label | Description | Also known as |
|---|---|---|---|
| English | Designs for Group Sequential Phase II Clinical Trials |
scientific article |
Statements
Designs for Group Sequential Phase II Clinical Trials (English)
0 references
1987
0 references
clinical trials
0 references
optimal design
0 references
